Budesonide and formoterol rapidly and effectively inhibit ERK1/2 phosphorylation in bradykinin-stimulated human lung fibroblasts

F. Sabatini, L. Petecchia, S. Boero, M. Silvestri, G. A. Rossi, F. L. M. Ricciardolo (Genoa, Turin, Italy)

Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Session: Novel experimental approaches to understanding asthma and COPD II
Session type: Thematic Poster Session
Number: 3662
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Sabatini, L. Petecchia, S. Boero, M. Silvestri, G. A. Rossi, F. L. M. Ricciardolo (Genoa, Turin, Italy). Budesonide and formoterol rapidly and effectively inhibit ERK1/2 phosphorylation in bradykinin-stimulated human lung fibroblasts. Eur Respir J 2008; 32: Suppl. 52, 3662

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006

17-beclomethasone monopropionate or inhibition of MAPK p38 signalling abolish IL-8 release stimulated by cigarette smoke extract or acrolein in normal human airway smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


Modulation of bradykinin (BK)-induced lung fibroblast proliferation and differentiation by budesonide (Bud) and formoterol (Form) involves the inhibition of ERK1/2 phosphorylation and Ca2+ mobilization
Source: Annual Congress 2009 - Translational models of lung disease
Year: 2009


Proteoglycan production in cultured human lung fibroblasts is synergistcally inhibited by combination of budesonide and formoterol
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003

Rapid inhibitory effects of budesonide and formoterol on bradykinin-induced Ca2+ mobilization in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

TGFβ-induced proteoglycan production and α-smooth muscle actin expression in cultured human lung fibroblasts is inhibited by combination of budesonide and formoterol
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004

N-Acetylcysteine inhibits eotaxin and MCP-1 release in human airway smooth muscle cells in vitro through the inhibition of ROS production, resulting in a decrease of p38 MAP kinase activation
Source: Eur Respir J 2002; 20: Suppl. 38, 170s
Year: 2002

Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003

LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Theophylline at the therapeutic concentrations abrogate decreased smad7 expression in cultured smooth muscle cells stimulated with LTD4 and EGF
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005

Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Dexamethasone and formoterol modulate human rhinovirus induced MMP-9 expression
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Formoterol is more potent and more effective than salmeterol in the inhibition of oxidative burst in human eosinophils
Source: Eur Respir J 2001; 18: Suppl. 33, 49s
Year: 2001

Synergistic inhibition of oxidative burst in human eosinophils by combination treatment with formoterol and budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Source: Eur Respir J 2008; 32: 555-562
Year: 2008



Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003

Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells
Source: Annual Congress 2010 - Models of airways disease
Year: 2010